Reuters logo
BRIEF-NeoGenomics and Definiens to develop novel assays for clinical trials & clinical testing
March 13, 2017 / 11:13 AM / 8 months ago

BRIEF-NeoGenomics and Definiens to develop novel assays for clinical trials & clinical testing

March 13 (Reuters) - NeoGenomics Inc-

* NeoGenomics and Definiens enter into agreement to develop novel assays for clinical trials & clinical testing

* Co, definiens expanded alliance to develop and automate analysis of new biomarker assays for clinical trials, routine clinical testing

* definiens to provide automated quantitative biomarker solutions to support neogenomics’ immunohistochemistry services Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below